Gentamicin Cream bulk supplier for pharma manufacturers

Gentamicin Cream 0.1% or 0.3% Suppliers & Bulk Manufacturers

Available Forms: Cream

Available Strengths: 0.1% or 0.3%

Reference Brands: Garamycin, Bramycin(US)

Gentamicin iv :Moa and benefits in 50 words OpenAI GPT-4o mini Gentamicin IV inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing faulty protein production and bacterial death. It provides rapid, broad-spectrum activity against serious gram-negative infections like sepsis and meningitis. Benefits include quick bacterial clearance, effective hospital use, and reliable coverage of multidrug-resistant bacteria when used properly.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Gentamicin Cream? List it or send an offer →

Product Description:

Gentamicin cream is approved in the EU and US for topical bacterial skin infections. In the EU, brands like Garamycin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. Due to its widespread use and safety, strict regulations on labeling, application, and storage are enforced. We facilitate seamless market access for gentamicin cream, adhering to European and US standards for safe, effective topical antibiotic therapy.

Gentamicin Cream — third party manufacturing & bulk supply

Gentamicin Cream 0.1% or 0.3% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gentamicin Cream is supplied as Cream — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gentamicin Cream listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gentamicin Cream →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Gentamicin cream is used for the topical treatment of skin infections caused by susceptible bacteria, including infected cuts, abrasions, burns, impetigo, folliculitis, and other minor skin infections. It helps reduce redness, swelling, and discharge while promoting healing of the affected area.

Gentamicin cream is made from gentamicin sulfate, an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis, leading to the death of susceptible bacteria.

Common trade names include Garamycin Cream, Genoptic Cream, Gentacin Cream, and various generic versions.

It is made by a number of companies in different countries, including India. We match each enquiry with licensed makers that can supply your market.

The generic name is gentamicin sulfate cream.

Brand names include Garamycin Cream, Genoptic Cream, Gentacin Cream, and other region-specific generics.

Gentamicin cream is manufactured worldwide, with major production in India, Europe, and the United States by both innovator and generic pharmaceutical companies.